Amgen (AMGN)

=== SEC Form 3 — Statement of Changes in Beneficial Ownership === Document Type: 3 Period of Report: 2026-09-01 --- Issuer --- Name: AMGEN INC (AMGN) CIK: 0000318154 --- Reporting Owner --- Name: Dittrich Thomas J.W. CIK: 0001491654 Role: Officer (EVP & CFO) --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) Footnotes: [F1] These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. [Holding #2] Security: Nqso (Right to Buy) Ownership: D (Direct) Footnotes: [F2] These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027. --- Footnotes (Complete Index) --- F1: These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2: These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027. --- Signature --- /s/ /s/ Thomas J.W. Dittrich (2026-09-03)